Topoisomerase-based reagents and methods for molecular cloning
AssigneeSloan-Kettering Institute for Cancer Research
InventorStewart Shuman
Life of this patent
Estimating the term…
Loading patent…
AssigneeSloan-Kettering Institute for Cancer Research
InventorStewart Shuman
Estimating the term…
This invention provides a modified vaccinia topoisomerase enzyme containing an affinity tag which is capable of facilitating purification of protein-DNA complexes away from unbound DNA. This invention further provides a modified sequence specific topoisomerase enzyme. This invention provides a method of ligating duplex DNAs, a method of molecular cloning of DNA, a method of synthesizing polynucleotides, and a method of gene targeting. Lastly, this invention provides a recombinant DNA molecule composed of segments of DNA which have been joined ex vivo by the use of a sequence specific topoisomerase and which has the capacity to transform a suitable host cell comprising a DNA sequence encoding polypeptide activity.
A modified vaccinia topoisomerase enzyme containing an affinity tag.
A method of ligating duplex DNAs comprising:
A method of molecular cloning DNA comprising:
A method of synthesizing polynucleotides comprising:
A method of gene targeting which comprises:
A recombinant DNA molecule composed of segments of DNA which have been joined ex vivo or in vitro by the use of a sequence specific topoisomerase and which has the capacity to transform a suitable host cell comprising a DNA sequence encoding polypeptide activity.
Dependencies are inferred from the claim text.